BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2438397)

  • 1. Antitrypanosomal action of cis-diamminedichloroplatinum (II) analogs.
    Osuna A; Ruiz-Perez LM; Lopez MC; Castanys S; Gamarro F; Craciunescu DG; Alonso C
    J Parasitol; 1987 Apr; 73(2):272-7. PubMed ID: 2438397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trypanosoma cruzi: incorporation of macromolecule precursors during the morphogenic process.
    Lammel EM; Turyn D; Isola EL
    Rev Argent Microbiol; 1992; 24(2):81-5. PubMed ID: 1298017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mode of action of intercalating drug, cis-Pt(II)(DDH)Cl2, cis-Pt(II)(DDH) (metafluorobenzoic)2, and cis-Pt(II)(DDH)(mucubromic)2, on Trypanosoma cruzi.
    Ruiz-Perez LM; Osuna A; Lopez MC; Castanys S; Gammaro F; Craciunescu D; Alonso C
    Trop Med Parasitol; 1987 Mar; 38(1):45-8. PubMed ID: 3299659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the toxicity of Rh(III) and Pt(II) complexes against Trypanosoma cruzi culture forms.
    Ruiz-Pérez LM; Osuna A; Castanys S; Gamarro F; Craciunescu D; Doadrio A
    Arzneimittelforschung; 1986; 36(1):13-6. PubMed ID: 3513774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of rhodium(III) complexes against Trypanosoma cruzi.
    Ruiz-Perez LM; Osuna A; Lopez MC; Gamarro F; Castanys S; Craciunescu D; Alonso C
    Arzneimittelforschung; 1988 Feb; 38(2):312-4. PubMed ID: 2453194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of pre-mRNA splicing by cisplatin and platinum analogs.
    Schmittgen TD; Ju JF; Danenberg KD; Danenberg PV
    Int J Oncol; 2003 Sep; 23(3):785-9. PubMed ID: 12888918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity and biochemical effectiveness of new organometallic complexes of osmium(III) against Leishmania donovani and Trypanosoma cruzi.
    Castilla JJ; Mesa-Valle CM; Sanchez-Moreno M; Arnedo T; Rosales MJ; Mascaro C; Craciunescu D; Osuna A
    Arzneimittelforschung; 1996 Oct; 46(10):990-6. PubMed ID: 8931894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quiescent LLC-PK1 cells as a model for cis-diamminedichloroplatinum(II) nephrotoxicity and modulation by thiol rescue agents.
    Montine TJ; Borch RF
    Cancer Res; 1988 Nov; 48(21):6017-24. PubMed ID: 2458831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of cis-diamminedichloroplatinum(II) on DNA synthesis and cell cycle progression in excision repair proficient and deficient Chinese hamster ovary cells.
    Sorenson CM; Eastman A
    Cancer Res; 1988 Dec; 48(23):6703-7. PubMed ID: 3180081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the bladder carcinogen N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide on nucleic acids and total protein content of bladder epithelium undergoing malignant change.
    Pai SH; Amaral L; Werthamer S; Zak FG
    Invest Urol; 1974 Mar; 11(5):392-5. PubMed ID: 4815625
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of nitroheterocyclic drugs on macromolecule synthesis and degradation in Trypanosoma cruzi.
    Goijman SG; Stoppani AO
    Biochem Pharmacol; 1985 Apr; 34(8):1331-6. PubMed ID: 2581582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of ouabain on an SPEV culture].
    Grebenshchikova VI; Chentsov IuS; Grigor'eva NI
    Tsitol Genet; 1978; 12(4):299-306. PubMed ID: 705880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the genotoxicity of cis-bis(3-aminoflavone)dichloroplatinum(II) in comparison with cis-DDP.
    Kosmider B; Wyszynska K; Janik-Spiechowicz E; Osiecka R; Zyner E; Ochocki J; Ciesielska E; Wasowicz W
    Mutat Res; 2004 Mar; 558(1-2):93-110. PubMed ID: 15036123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiological events in the course of the growth and differentiation of Trypanosoma cruzi.
    Fernandes JF; Castellani O; Kimura E
    Genetics; 1969; 61(1):Suppl:213-26. PubMed ID: 5345381
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes in cell cycle and RNA content in cultured cancer cells treated with cis-diamminedichloroplatinum (II)].
    Tagawa Y; Kunisaki T; Oh S; Ishikawa H; Kajiwara K; Mine Y; Tasiro H; Ayabe H; Tomita M
    Hum Cell; 1988 Jun; 1(2):233-7. PubMed ID: 2979200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cis-diamminedichloroplatinum(II) and other platinum compounds on the RNA polymerase reaction.
    Ganeva R; Spassovska N; Genchev D
    Cytobios; 1994; 77(309):81-6. PubMed ID: 8020247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of carcinogenic nitrosamines and nitrosamides on the incroporation of 3H-thymidine, 3H-uridine and 3H-leucine into Tetrahymena, L-cells and liver explants].
    Volm M; Süss R
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 261(4):353-9. PubMed ID: 4235436
    [No Abstract]   [Full Text] [Related]  

  • 18. Cisplatin-DNA adducts inhibit ribosomal RNA synthesis by hijacking the transcription factor human upstream binding factor.
    Zhai X; Beckmann H; Jantzen HM; Essigmann JM
    Biochemistry; 1998 Nov; 37(46):16307-15. PubMed ID: 9819223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of the extent of platination and the sites of Pt binding after interaction of cis- and trans-diamminedichloroplatinum(II) with DNA and chromatin.
    Oliński R; Wiaderkiewicz R; Walter Z
    Acta Biochim Pol; 1985; 32(2):119-25. PubMed ID: 4041106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro action of platinum (II) and platinum (IV) complexes on Trypanosoma cruzi and Leishmania donovani.
    Mesa-Valle CM; Craciunescu D; Parrondo-Iglesias E; Osuna A
    Arzneimittelforschung; 1989 Aug; 39(8):838-42. PubMed ID: 2684173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.